DHG Pharmaceutical JSC 2018 SR
The report highlights DHG Pharma's 2018 performance, marking its 22nd consecutive year as the leader in the Vietnamese pharmaceutical industry. Key achievements include obtaining PIC/s - GMP and Japan - GMP certifications for production lines, facilitating exports to developed markets. The company successfully lifted its foreign ownership limit to 100%, strengthening its strategic partnership with Taisho. Sustainability efforts focused on the 'For a more beautiful and healthier life' mission, providing free medical care to over 25,000 people and investing VND 2.7 billion in employee training. Environmental initiatives resulted in a 9.34% reduction in electricity intensity.
Company: DHG Pharmaceutical JSC
Sector: Manufacturing
Country: Vietnam
Year: 2018
Type: SR
Pages: 81
DHG Pharmaceutical JSC
The report highlights DHG Pharma's 2018 performance, marking its 22nd consecutive year as the leader in the Vietnamese pharmaceutical industry. Key achievements include obtaining PIC/s - GMP and Japan - GMP certifications for production lines, facilitating exports to developed markets. The company successfully lifted its foreign ownership limit to 100%, strengthening its strategic partnership with Taisho. Sustainability efforts focused on the 'For a more beautiful and healthier life' mission, providing free medical care to over 25,000 people and investing VND 2.7 billion in employee training. Environmental initiatives resulted in a 9.34% reduction in electricity intensity.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Women in Management
Workplace Fatalities
Employees